These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12232483)

  • 1. Significance of surgery in the multimodality treatment of rectal cancer.
    Willeke F; Von Gerstenbergk-Helldorf B
    Onkologie; 2002 Aug; 25(4):324-32. PubMed ID: 12232483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rectal carcinoma--oncologically adequate resection].
    Simon D
    Praxis (Bern 1994); 2001 Apr; 90(14):575-80. PubMed ID: 11320884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adjuvant and neoadjuvant radiochemotherapy of rectal carcinoma].
    Sauer R; Rödel C
    Praxis (Bern 1994); 2002 Sep; 91(37):1476-84. PubMed ID: 12360683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Present treatment strategies for rectal carcinoma].
    Liersch T; Langer C; Ghadimi BM; Becker H
    Chirurg; 2005 Mar; 76(3):309-32; quiz 333-4. PubMed ID: 15739059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications for neoadjuvant therapy in rectal carcinoma].
    Zimmermann F; Molls M
    Chirurg; 2003 Oct; 74(10):887-96. PubMed ID: 14605730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rectal carcinoma. Optimizing treatment by neoadjuvant and adjuvant therapy?].
    Fasolini F
    Zentralbl Chir; 1999; 124(5):441-5. PubMed ID: 10420532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal cancer.
    McCourt M; Armitage J; Monson JR
    Surgeon; 2009 Jun; 7(3):162-9. PubMed ID: 19580180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
    Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
    Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The optimult study concept - selective neoadjuvant chemoradiation therapy based on preoperative MRI].
    Kreis ME; Junginger T; Rödel C; Heinemann V; Nikolaou K; Mansmann U; Jauch KW
    Zentralbl Chir; 2010 Aug; 135(4):302-6. PubMed ID: 20806131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neoadjuvant and adjuvant radiochemotherapy for rectal carcinoma].
    Seegenschmiedt MH
    MMW Fortschr Med; 2007 Jun; 149(23):33-5. PubMed ID: 18062575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgery treatment of rectal cancer].
    Bretagnol F; de Calan L
    J Chir (Paris); 2006; 143(6):366-72. PubMed ID: 17285082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy?
    Hughes R; Harrison M; Glynne-Jones R
    Acta Oncol; 2010 Apr; 49(3):378-81. PubMed ID: 20151936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of combined-modality therapy in the management of locally advanced rectal cancer.
    Hosein PJ; Rocha-Lima CM
    Clin Colorectal Cancer; 2008 Nov; 7(6):369-75. PubMed ID: 19036689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer.
    Lutz MP; Zalcberg JR; Glynne-Jones R; Ruers T; Ducreux M; Arnold D; Aust D; Brown G; Bujko K; Cunningham C; Evrard S; Folprecht G; Gerard JP; Habr-Gama A; Haustermans K; Holm T; Kuhlmann KF; Lordick F; Mentha G; Moehler M; Nagtegaal ID; Pigazzi A; Pucciarelli S; Roth A; Rutten H; Schmoll HJ; Sorbye H; Van Cutsem E; Weitz J; Otto F
    Eur J Cancer; 2016 Aug; 63():11-24. PubMed ID: 27254838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
    Madbouly KM; Hussein AM; Abdelzaher E
    Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer of the upper rectum.
    Bondeven P
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer.
    Sclafani F; Cunningham D
    Future Oncol; 2014 Nov; 10(14):2243-57. PubMed ID: 25471037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
    Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
    Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer.
    Gollins S
    Colorectal Dis; 2010 Aug; 12 Suppl 2():2-24. PubMed ID: 20618363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.